• Simcere Pharmaceutical Group, of Nanjing, China, said the Chinese State Food and Drug Administration issued its approval for GMP certification of the influenza vaccine production facility at subsidiary Jiangsu Simcere Vaxtec Bio-Pharmaceutical Co. Ltd.